Volume 5.06 | Feb 21

Prostate Cell News 5.06 February 21, 2014
Prostate Cell News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  Prostate Cell News on Twitter
 
TOP STORY
Aberrant Presentation of HPA-Reactive Carbohydrates Implies Selectin-Independent Metastasis Formation in Human Prostate Cancer
Researchers investigated the impact of prostate cancer (PCa) cell surface glycosylation as part of the tumor cell-endothelial cell interaction in prostate cancer metastasis. Glycosyltransferase expression was profiled in metastasis-derived PCa cell lines and compared with primary epithelium. PCa cells were examined for HPA- and selectin-binding and adhesion to endothelium. [Clin Cancer Res] Abstract
ProstaCult™: Serum-Free, BPE-Free Medium for Mouse Prostate Colony Assays - FREE Sample Request
 
PUBLICATIONS (Ranked by impact factor of the journal)
LABORATORY RESEARCH

Species-Specific Homing Mechanisms of Human Prostate Cancer Metastasis in Tissue Engineered Bone
Researchers aimed to engineer a morphologically and functionally intact humanized organ bone which can serve as a homing site for human prostate cancer cells. [Biomaterials] Abstract

Anticancer Effects of Gemcitabine Are Enhanced by Co-Administered iRGD Peptide in Murine Pancreatic Cancer Models that Overexpressed Neuropilin-1
Investigators report a novel combination chemotherapy using gemcitabine (GEM) and internalized-RGD (iRGD) peptide, which enhances tumor-specific drug penetration by binding neuropilin-1 (NRP1) receptor. A total of five pancreatic cancer murine models (two cell line-based xenografts and three tumor grafts) were treated with either GEM alone or GEM plus iRGD peptide. [Br J Cancer] Abstract

Paracrine Interactions between LNCaP Prostate Cancer Cells and Bioengineered Bone in 3D In Vitro Culture Reflect Molecular Changes during Bone Metastasis
To better understand the pathophysiology of bone metastasis, scientists have established and validated a 3D indirect co-culture model to investigate the paracrine interactions between prostate cancer cells and human osteoblasts. [Bone] Abstract

Subditine, a New Monoterpenoid Indole Alkaloid from Bark of Nauclea subdita (Korth.) Steud. Induces Apoptosis in Human Prostate Cancer Cells
Data demonstrated that the new compound subditine exerts anti-proliferative effect on LNCaP and PC-3 human prostate cancer cells through induction of apoptosis. [PLoS One] Full Article

Autophagy Pathway Is Required for IL-6 Induced Neuroendocrine Differentiation and Chemoresistance of Prostate Cancer LNCaP Cells
To clarify the effect of autophagy on neuroendocrine differentiation, androgen-sensitive prostate cancer LNCaP cells were examined. Treatment of LNCaP cells with IL-6 resulted in an induction of autophagy. [PLoS One]
Full Article


Enhanced Detection of Metastatic Prostate Cancer Cells in Human Plasma with Lipid Bodies Staining
Energy metabolism was examined as a function of incubation in nutrient-rich plasma in prostate metastatic cancer cells LNCaP and non-transformed prostate epithelial cells RWPE1. Uptake kinetics of a fluorescent glucose analog and lipophilic dyes were measured in both cell lines, as well as in peripheral blood mononuclear cells. [BMC Cancer] Full Article

CXCR4 and PTEN Are Involved in the Anti-Metastatic Regulation of Anethole in DU145 Prostate Cancer Cells
Researchers aimed to understand the anti-metastatic effect of anethole through C-X-C chemokine receptor type 4 (CXCR4)/tumor suppressor phosphatase and tensin homologue (PTEN) axis in DU145 prostate cancer cells. [Biochem Biophys Res Commun] Abstract

CLINICAL RESEARCH

Frequent Germline Deleterious Mutations in DNA Repair Genes in Familial Prostate Cancer Cases Are Associated with Advanced Disease
The authors used second-generation sequencing technology to assess the frequency of deleterious mutations in 22 tumor suppressor genes in familial prostate cancer (PrCa) and estimate the relative risk of PrCa if these genes are mutated. [Brit J Cancer] Abstract | Press Release

Long Term Oncologic Outcomes of a Phase II Trial of Neoadjuvant Chemohormonal Therapy followed by Radical Prostatectomy for Patients with Clinically Localized, High-Risk Prostate Cancer
High-risk PCa patients treated with neoadjuvant chemohormonal therapy followed by prostatectomy experienced a trend toward improvement in metastatic-free and overall survival when compared with high-risk patients undergoing prostatectomy alone; however this trend did not reach significance. [BJU Int] Abstract

Win a $25 Amazon Gift Card!
Connexon Creative is evaluating reader interest in a new social media platform. Fill out this quick survey for your chance to win 1 of 4 $25 gift cards! Take survey here


[Free Webinar] A Guide To Successful Flow Cytometry Analysis of ALDHbr Cells - Watch Now.
 
REVIEWS
Small Cell Carcinoma of the Prostate
Chemotherapy is the standard approach for treating patients with either localized or advanced prostatic small-cell carcinoma (SCC). Despite the emergence of more-aggressive treatment modalities, the prognosis of men with prostatic SCC remains dismal. [Nat Rev Urol] Abstract

Visit our reviews page to see a complete list of reviews in the prostate cell research field.
 
INDUSTRY NEWS
AB Science: Initiation of a New Phase III Study with Masitinib in Prostate Cancer, following Encouraging Survival Results Obtained in a Phase II Study
AB Science SA announced the initiation of a Phase III study to evaluate the safety and efficacy of masitinib in combination with docetaxel in first line treatment of metastatic castrate resistant prostate cancer. [GlobeNewswire, Inc.] Press Release

Hormel Institute Researcher’s Work Highlighted Nationally
Promising research focused on effectively attacking a form of prostate cancer resistant to chemotherapy is being recognized nationally by the U.S. Department of Defense. Dr. Mohammad Saleem had work recently featured as one of three prostate cancer research projects included in the Department of Defense’s “2014 Research Highlights” section. [The Hormel Institute] Press Release

New wallchart from our sponsor:
Mesenchymal Stem Cells (a Nature Reviews Molecular Cell Biology collaboration). Request your free copy.
 
POLICY NEWS
AAAS Launches Open-Access Journal
Joining a herd of other scientific societies, American Association for the Advancement of Science (AAAS) announced that it will launch the organization’s first online, fully open-access journal early next year. The new journal, called Science Advances, will give authors another outlet for papers that they are willing to pay to make immediately free to the public. [ScienceInsider] Editorial

National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW 15th Asia-Pacific Prostate Cancer Conference (APCC) 2014
August 31-September 2, 2014
Melbourne, Australia

Visit our events page to see a complete list of events in the prostate cell community.
 
JOB OPPORTUNITIES
NEW Postdoctoral Fellow – Prostate Cancer (Mayo Clinic- Rochester)

Postdoctoral Fellow – Biomarker Discovery In Prostate Cancer (University of California, San Francisco)

Postdoctoral Position- Cancer Biology/Genomics (Weill Cornell Medical College)

Experienced Researcher – Detection of Prostate Cancer Biomarkers (Dublin City University)

Postdoctoral Fellow – Role of Mitochondria in Cancer Progression (Baylor College of Medicine)

Postdoctoral Position – Prostate Cancer (Roswell Park Cancer Institute)

Postdoctoral Position – Prostate Molecular Oncology (Trinity College Dublin)

Postgraduate Position – Chemokine Receptor Induced Cell Migration (University of East Anglia)

Graduate Student Position – Epigenetics and Chromatin (University of Victoria)

Postdoctoral Fellow – Mechanism of Prostate Cancer Bone Metastasis (Georgia Regents University)

Research Technologist – Pluripotent Stem Cells (STEMCELL Technologies Inc.)

Research Technologist – Particle Chemistry (STEMCELL Technologies Inc.)

Research Technologist – PSC Biology and Bioengineering (STEMCELL Technologies Inc.)


Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Prostate Cell News? Click here to submit!

Comments or Suggestions? Submit your feedback here.
Learn more about Prostate Cell News: Archives | Events | Contact Us